Product Images Tazicef

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Tazicef NDC 0409-5093 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - tazicef 01

Chemical Structure - tazicef 01

tazicef 01a

tazicef 01a

Fig 1 and 2 - tazicef 02

Fig 1 and 2 - tazicef 02

Fig 3 and 4 - tazicef 03

Fig 3 and 4 - tazicef 03

Fig 5 and 6 - tazicef 04

Fig 5 and 6 - tazicef 04

Hospira logo - tazicef 05

Hospira logo - tazicef 05

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label - tazicef 06

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label - tazicef 06

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton - tazicef 07

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton - tazicef 07

This is a description of Ceftazidime, a medication used for intravenous infusion to treat bacterial infections. It comes in single-dose ADD-Vantage containers for adult use only. The reconstituted solution is stable for 24 hours at room temperature. It is important to store the medication at a temperature range of 20°C to 25°C before reconstitution. Each vial contains Ceftazidime at 1-gram strength per vial with additional sodium carbonate. The medication is manufactured by Sandoz GmbH for Hospira Inc. The text also includes the NDC code and prescribing information with dosage instructions.*

PRINCIPAL DISPLAY PANEL - 2 gram Vial Label - tazicef 08

PRINCIPAL DISPLAY PANEL - 2 gram Vial Label - tazicef 08

This is a product description for Ceftazidime, a medication used for intravenous infusion to treat bacterial infections. The medication is contained in single-dose ADD-Vantage vials that make it easy to mix with the appropriate solution and dose. The text specifies that there are 25 vials per order and the equivalent to 1-gram or gram/vial of Ceftazidime. The product is manufactured by Hospira and intended for use only under the prescription of a physician.*

PRINCIPAL DISPLAY PANEL - 2 gram Vial Carton - tazicef 09

PRINCIPAL DISPLAY PANEL - 2 gram Vial Carton - tazicef 09

This is a prescription drug called Tazicef or Ceftazidime used for intravenous infusion only. The contents of each vial are 2 grams of Ceftazidime and 236 mg of Sodium carbonate. The drug comes in an ADD-Vantage® container and each vial contains sodium equivalent to approximately 5 mg or 23mEq per gram of ceftazidime activity. The drug is stable for 24 hours at room temperature after reconstitution, and slight yellowing does not affect potency. The recommended dosage for adults is not specified.*

tazicef 10

tazicef 10

This is a description of TAZICEF® a Ceftazidime injection used for intravenous infusion. It is available in single-dose ADD-Vantage® vials which are equivalent to 2 g/vial. The product is only available with a prescription. The provided text also contains product codes (NDC 0409-5003-11 and NDG 0409-5093-14) which might be useful to identify the product in a database.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.